debate about whether to use ezetimibe (Vytorin, Zetia) for dyslipidemia

You'll hear more debate about whether to use ezetimibe (Vytorin, Zetia) for dyslipidemia.

Ezetimibe works well to lower LDL and is well tolerated...but it keeps coming up short in comparative trials.

The latest data suggest that ezetimibe doesn't reduce arterial plaque as well as niacin...when these drugs are added to a statin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote